Request Sample Inquiry
Chronic Lower Back Pain Market

Chronic Lower Back Pain Market

Chronic Lower Back Pain Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

210

Base Year:

2023

Date

Oct - 2024

Format:

PDF XLS PPT

Report Code:

VMR-2975

Segments Covered
  • By Drug Class By Drug Class Non-steroidal Anti-Inflammatory Drugs, Antidepressants, Analgesic, Opioids, Others
  • By Route of Administration By Route of Administration Oral, Topical, Others
  • By Distribution Channel By Distribution Channel Hospital Pharmacies, Retail & Online Pharmacies
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2023
Forecast YearsForecast Years: 2024 - 2032
Historical YearsHistorical Years: 2018 - 2022
Revenue 2023Revenue 2023: USD 2.5 Billion
Revenue 2032Revenue 2032: USD 5.52 Billion
Revenue CAGRRevenue CAGR (2024 - 2032): 9.2%
Fastest Growing Region Fastest Growing Region (2024 - 2032) Asia Pacific
Largest Region Largest Region (2023): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
  1. Executive Dashboard
    1. Strategic Imperatives
  2. Premium Insights
    1. Top 3 Trends to Watch
    2. Demand and Supply Trends
    3. Top 3 Strategies Followed by Major Players
    4. Top 3 Predictions by Vantage Market Research
    5. Top Investment Pockets
    6. Insights from Primary Respondents
  3. Global Chronic Lower Back Pain Market - Segment Analysis
    1. Overview
    2. Global Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
    3. Global Chronic Lower Back Pain Market - by Drug Class
      1. By Non-steroidal Anti-Inflammatory Drugs
      2. By Antidepressants
      3. By Analgesic
      4. By Opioids
      5. By Others
    4. Global Chronic Lower Back Pain Market - by Route of Administration
      1. By Oral
      2. By Topical
      3. By Others
    5. Global Chronic Lower Back Pain Market - by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail & Online Pharmacies
    6. Global Chronic Lower Back Pain Market - by region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    7. Market comparative analysis
  4. North America Chronic Lower Back Pain Market - Segment Analysis
    1. Overview
    2. North America Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
    3. North America Chronic Lower Back Pain Market, by Drug Class
      1. By Non-steroidal Anti-Inflammatory Drugs
      2. By Antidepressants
      3. By Analgesic
      4. By Opioids
      5. By Others
    4. North America Chronic Lower Back Pain Market, by Route of Administration
      1. By Oral
      2. By Topical
      3. By Others
    5. North America Chronic Lower Back Pain Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail & Online Pharmacies
    6. North America Chronic Lower Back Pain Market, by Country
      1. U.S.
        1. U.S. Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. U.S. Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. U.S. Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      2. Canada
        1. Canada Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Canada Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Canada Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      3. Mexico
        1. Mexico Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Mexico Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Mexico Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
  5. Europe Chronic Lower Back Pain Market - Segment Analysis
    1. Overview
    2. Europe Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
    3. Europe Chronic Lower Back Pain Market, by Drug Class
      1. By Non-steroidal Anti-Inflammatory Drugs
      2. By Antidepressants
      3. By Analgesic
      4. By Opioids
      5. By Others
    4. Europe Chronic Lower Back Pain Market, by Route of Administration
      1. By Oral
      2. By Topical
      3. By Others
    5. Europe Chronic Lower Back Pain Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail & Online Pharmacies
    6. Europe Chronic Lower Back Pain Market, by Country
      1. Germany
        1. Germany Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Germany Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Germany Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      2. UK
        1. UK Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. UK Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. UK Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      3. France
        1. France Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. France Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. France Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      4. Spain
        1. Spain Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Spain Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Spain Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      5. Italy
        1. Italy Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Italy Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Italy Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      6. BENELUX
        1. BENELUX Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. BENELUX Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. BENELUX Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      7. Rest of Europe
        1. Rest Of Europe Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Rest Of Europe Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Rest Of Europe Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
  6. Asia Pacific Chronic Lower Back Pain Market - Segment Analysis
    1. Overview
    2. Asia Pacific Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
    3. Asia Pacific Chronic Lower Back Pain Market, by Drug Class
      1. By Non-steroidal Anti-Inflammatory Drugs
      2. By Antidepressants
      3. By Analgesic
      4. By Opioids
      5. By Others
    4. Asia Pacific Chronic Lower Back Pain Market, by Route of Administration
      1. By Oral
      2. By Topical
      3. By Others
    5. Asia Pacific Chronic Lower Back Pain Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail & Online Pharmacies
    6. Asia Pacific Chronic Lower Back Pain Market, by Country
      1. China
        1. China Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. China Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. China Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      2. Japan
        1. Japan Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Japan Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Japan Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      3. India
        1. India Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. India Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. India Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      4. South Korea
        1. South Korea Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. South Korea Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. South Korea Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      5. South East Asia
        1. South East Asia Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. South East Asia Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. South East Asia Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      6. Rest of Asia Pacific
        1. Rest of Asia Pacific Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Rest of Asia Pacific Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Rest of Asia Pacific Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
  7. Latin America Chronic Lower Back Pain Market - Segment Analysis
    1. Overview
    2. Latin America Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
    3. Latin America Chronic Lower Back Pain Market, by Drug Class
      1. By Non-steroidal Anti-Inflammatory Drugs
      2. By Antidepressants
      3. By Analgesic
      4. By Opioids
      5. By Others
    4. Latin America Chronic Lower Back Pain Market, by Route of Administration
      1. By Oral
      2. By Topical
      3. By Others
    5. Latin America Chronic Lower Back Pain Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail & Online Pharmacies
    6. Latin America Chronic Lower Back Pain Market, by Country
      1. Brazil
        1. Brazil Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Brazil Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Brazil Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      2. Argentina
        1. Argentina Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Argentina Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Argentina Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      3. Rest of Latin America
        1. Rest of Latin America Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Rest of Latin America Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Rest of Latin America Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
  8. Middle East & Africa Chronic Lower Back Pain Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Chronic Lower Back Pain Market, 2016 - 2028 (USD Million)
    3. Middle East & Africa Chronic Lower Back Pain Market, by Drug Class
      1. By Non-steroidal Anti-Inflammatory Drugs
      2. By Antidepressants
      3. By Analgesic
      4. By Opioids
      5. By Others
    4. Middle East & Africa Chronic Lower Back Pain Market, by Route of Administration
      1. By Oral
      2. By Topical
      3. By Others
    5. Middle East & Africa Chronic Lower Back Pain Market, by Distribution Channel
      1. By Hospital Pharmacies
      2. By Retail & Online Pharmacies
    6. Middle East & Africa Chronic Lower Back Pain Market, by Country
      1. GCC Countries
        1. GCC Countries Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. GCC Countries Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. GCC Countries Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      2. South Africa
        1. South Africa Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. South Africa Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. South Africa Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
      3. Rest of Middle East & Africa
        1. Rest of Middle East & Africa Chronic Lower Back Pain Market, By Drug Class
          1. By Non-steroidal Anti-Inflammatory Drugs
          2. By Antidepressants
          3. By Analgesic
          4. By Opioids
          5. By Others
        2. Rest of Middle East & Africa Chronic Lower Back Pain Market, By Route of Administration
          1. By Oral
          2. By Topical
          3. By Others
        3. Rest of Middle East & Africa Chronic Lower Back Pain Market, By Distribution Channel
          1. By Hospital Pharmacies
          2. By Retail & Online Pharmacies
  9. Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter's Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
  10. COVID 19 Impact Analysis
    1. Key strategies undertaken by companies to tackle COVID-19
    2. Short term dynamics
    3. Long term dynamics
  11. Marketing Stratagy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
  12. Competative Landscape
    1. Competition Matrix - 2021
    2. Company Market Share Analysis - 2021
    3. Key Company Activities, 2018 - 2021
    4. Strategic Developments - Heat Map Analysis
    5. Company Offering Evaluation
    6. Company Regional Presence Evaluation
  13. Company Profiles
    1. Johnson & Johnson Private Limited
    2. Medtronic
    3. Endo Pharmaceuticals Inc.
    4. Sanofi
    5. Merck & Co Inc.
    6. Koninklijke Philips N.V.
    7. Vertebral Technologies Inc.
    8. Boston Scientific Corporation
    9. Dr. Reddy’s Laboratories Ltd.
    10. Astellas Pharma Inc.
    11. SpineThera Inc.
    12. Pfizer Inc
    13. Teva Pharmaceutical Industries Ltd.
  14. Key Primary Respondents - VERBATIM
  15. Discussion Guide
  16. Customization Offered
  17. Annexure
  18. List of Figures
  19. List of Tables
  20. List of Abbreviations
FAQ
Frequently Asked Question
  • The global Chronic Lower Back Pain valued at USD 2.5 Billion in 2023 and is expected to reach USD 5.52 Billion in 2032 growing at a CAGR of 9.2%.

  • The prominent players in the market are Johnson & Johnson Private Limited, Medtronic, Endo Pharmaceuticals Inc., Sanofi, Merck & Co Inc., Koninklijke Philips N.V., Vertebral Technologies, Inc., Boston Scientific Corporation, Dr. Reddy’s Laboratories Ltd., Astellas Pharma Inc., SpineThera Inc., Pfizer Inc, Teva Pharmaceutical Industries Ltd..

  • The market is project to grow at a CAGR of 9.2% between 2024 and 2032.

  • The driving factors of the Chronic Lower Back Pain include

  • North America was the leading regional segment of the Chronic Lower Back Pain in 2023.